1383 related articles for article (PubMed ID: 19303440)
1. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
[TBL] [Abstract][Full Text] [Related]
4. Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes.
Connor SC; Hansen MK; Corner A; Smith RF; Ryan TE
Mol Biosyst; 2010 May; 6(5):909-21. PubMed ID: 20567778
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics: available results, current research projects in breast cancer, and future applications.
Claudino WM; Quattrone A; Biganzoli L; Pestrin M; Bertini I; Di Leo A
J Clin Oncol; 2007 Jul; 25(19):2840-6. PubMed ID: 17502626
[TBL] [Abstract][Full Text] [Related]
6. Knowledge discovery in metabolomics: an overview of MS data handling.
Boccard J; Veuthey JL; Rudaz S
J Sep Sci; 2010 Feb; 33(3):290-304. PubMed ID: 20087872
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic receptors in psychiatric disorders - can we mimic 'health'?
Scarr E
Neurosignals; 2009; 17(4):298-310. PubMed ID: 19816066
[TBL] [Abstract][Full Text] [Related]
8. The complex links between dietary phytochemicals and human health deciphered by metabolomics.
Manach C; Hubert J; Llorach R; Scalbert A
Mol Nutr Food Res; 2009 Oct; 53(10):1303-15. PubMed ID: 19764066
[TBL] [Abstract][Full Text] [Related]
9. Involvement of non-opioid peptides in the pathogenesis of neurological and psychiatric disorders: evidence from CSF and post-mortem studies.
Nemeroff CB; Bissette G
Prog Clin Biol Res; 1985; 192():333-41. PubMed ID: 2934745
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function.
Teixeira AL; Barbosa IG; Diniz BS; Kummer A
Biomark Med; 2010 Dec; 4(6):871-87. PubMed ID: 21133708
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria and neurodegeneration.
Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
[TBL] [Abstract][Full Text] [Related]
12. New insights into cardiovascular and lipid metabolomics.
Giovane A; Balestrieri A; Napoli C
J Cell Biochem; 2008 Oct; 105(3):648-54. PubMed ID: 18729082
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics: a new tool for the neonatologist.
Atzori L; Antonucci R; Barberini L; Griffin JL; Fanos V
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():50-3. PubMed ID: 19701858
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics reviewed: a new "omics" platform technology for systems biology and implications for natural products research.
Rochfort S
J Nat Prod; 2005 Dec; 68(12):1813-20. PubMed ID: 16378385
[TBL] [Abstract][Full Text] [Related]
15. New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism.
Horrobin DF; Bennett CN
Prostaglandins Leukot Essent Fatty Acids; 1999 Mar; 60(3):141-67. PubMed ID: 10359017
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression.
Marek K; Jennings D; Tamagnan G; Seibyl J
Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways.
Xu EY; Schaefer WH; Xu Q
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):40-52. PubMed ID: 19152212
[TBL] [Abstract][Full Text] [Related]
18. Genes and the environment in neurodegeneration.
Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics: a global biochemical approach to the study of central nervous system diseases.
Kaddurah-Daouk R; Krishnan KR
Neuropsychopharmacology; 2009 Jan; 34(1):173-86. PubMed ID: 18843269
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in Huntington's and Parkinson's Disease.
O'Keeffe GC; Michell AW; Barker RA
Ann N Y Acad Sci; 2009 Oct; 1180():97-110. PubMed ID: 19906264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
